Know Cancer

or
forgot password

Making Accurate Problem Lists in the EHR


N/A
18 Years
N/A
Open (Enrolling by invite only)
Both
Attention Deficit Disorder With Hyperactivity, Asthma, COPD, Breast Cancer, Coronary Artery Disease, Congestive Heart Failure, Diabetes, Glaucoma, Hemophilia, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Osteopenia, Renal Failure, Renal Insufficiency, Sickle Cell Disease, Stroke

Thank you

Trial Information

Making Accurate Problem Lists in the EHR


The clinical problem list is a cornerstone of the problem-oriented medical record. Problem
lists are used in a variety of ways throughout the process of clinical care. In addition to
its use by clinicians, the problem list is also critical for decision support and quality
measurement.

Patients with gaps in their problem list face significant risks. For example, if a
hypothetical patient has diabetes properly documented, his clinician would receive
appropriate alerts and reminders to guide care. Additionally, the patient might be included
in special care management programs and the quality of care provided to him would be
measured and tracked. Without diabetes on his problem list, he might receive none of these
benefits.

In this study, the investigators developed an clinical decision support intervention that
will identify patients with problem lists gaps. The investigators will alert providers of
these likely gaps and offer providers the opportunity to correct them.


Inclusion Criteria:



- Independent healthcare provider (physician, NP, PA)

- Practices at participating site

Exclusion Criteria:

- None

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Intervention acceptance

Outcome Description:

Of those providers who were shown (or who would have been shown, for the control group) the intervention, the number that added a problem across control and intervention groups.

Outcome Time Frame:

6 months (May 2010-Nov2010)

Safety Issue:

No

Principal Investigator

Adam Wright, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Brigham and Women's Hospital

Authority:

United States: Institutional Review Board

Study ID:

2009P001846

NCT ID:

NCT01105923

Start Date:

May 2010

Completion Date:

November 2010

Related Keywords:

  • Attention Deficit Disorder With Hyperactivity
  • Asthma
  • COPD
  • Breast Cancer
  • Coronary Artery Disease
  • Congestive Heart Failure
  • Diabetes
  • Glaucoma
  • Hemophilia
  • Hypertension
  • Hyperthyroidism
  • Hypothyroidism
  • Myasthenia Gravis
  • Osteoporosis
  • Osteopenia
  • Renal Failure
  • Renal Insufficiency
  • Sickle Cell Disease
  • Stroke
  • Anemia, Sickle Cell
  • Asthma
  • Breast Neoplasms
  • Coronary Artery Disease
  • Myocardial Ischemia
  • Coronary Disease
  • Glaucoma
  • Heart Failure
  • Hemophilia A
  • Hypertension
  • Hyperthyroidism
  • Hypothyroidism
  • Myasthenia Gravis
  • Bone Diseases, Metabolic
  • Osteoporosis
  • Renal Insufficiency
  • Stroke
  • Attention Deficit Disorder with Hyperactivity
  • Hyperkinesis

Name

Location

Brigham and Women's HospitalBoston, Massachusetts  02115